Literature DB >> 8004581

Patterns of lymphatic spread in thoracic esophageal cancer.

T Nishimaki1, O Tanaka, T Suzuki, K Aizawa, K Hatakeyama, T Muto.   

Abstract

BACKGROUND: The cervical nodes have been excluded from the category of regional nodes in cases of thoracic esophageal cancer in the present TNM classifications.
METHODS: One hundred and forty-one patients with thoracic esophageal cancer who had undergone extensive radical lymphadenectomy were included in the study. The patterns of early lymph node metastasis from the disease, in terms of lymph node metastases from the intramural tumors or those found in patients with a single metastatic node, were studied. Prognostic significance of the removal of the positive nodes also was examined in relation to the metastatic sites.
RESULTS: Of the 47 patients with intramural cancer, only 21% had nodal metastases confined to the mediastinum, 11% had positive cervical nodes, and 23% had jumping metastases to the extramediastinal nodes. Of the 31 patients with a single metastatic node, 61% showed metastasis in a jumping fashion, and 19% had a positive node in the neck. Seventy-four (79.6%) of the 93 patients with vessel invasion also had lymph node metastases, whereas 20 (41.7%) of the 48 patients without vessel invasion had metastases to the lymph nodes (P < 0.001). The 5-year projected survival rate for patients with positive cervical nodes was 27%, with no significant difference in survival rate compared with that for patients with metastatic nodes in the mediastinum or the abdomen. The number of involved nodes was related significantly to outcome: The 5-year survival rates for the 45 patients with negative nodes the 66 patients with one to four positive nodes were 71.8 and 34.2%, respectively (P < 0.01), whereas none of the 27 patients with five or more positive nodes survived more than 3 years after the operation (P < 0.001).
CONCLUSIONS: The cervical nodes should be included in the category of regional nodes in cases of thoracic esophageal cancer on the basis of the patterns of early lymph node metastases and the prognostic significance of a lymphadenectomy for metastases to these nodes.

Entities:  

Mesh:

Year:  1994        PMID: 8004581     DOI: 10.1002/1097-0142(19940701)74:1<4::aid-cncr2820740103>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  17 in total

Review 1.  High grade dysplasia: surveillance, mucosal ablation, or resection?

Authors:  Robert J Korst; Nasser K Altorki
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

2.  A meta-analysis of lymph node metastasis rate for patients with thoracic oesophageal cancer and its implication in delineation of clinical target volume for radiation therapy.

Authors:  X Ding; J Zhang; B Li; Z Wang; W Huang; T Zhou; Y Wei; H Li
Journal:  Br J Radiol       Date:  2012-06-14       Impact factor: 3.039

3.  Determination of primary foci of metastatic tumors by p53 mutational analysis in intraesophageal multiple carcinomas.

Authors:  S Kuwabara; T Nishimaki; Y Ajioka; S Komukai; T Suzuki; H Watanabe; K Hatakeyama
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

4.  Evaluating the rational extent of dissection in radical esophagectomy for invasive carcinoma of the thoracic esophagus.

Authors:  T Nishimaki; T Suzuki; Y Tanaka; S Nakagawa; K Aizawa; K Hatakeyama
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

5.  BRF2 as a promising indicator for radical lymph-node dissection surgery in patients with cN0 squamous cell carcinoma of the middle thoracic esophagus.

Authors:  Yu Tian; Cong Wang; Ming Lu
Journal:  Surg Today       Date:  2018-09-04       Impact factor: 2.549

6.  Limited resection for early esophageal cancer?

Authors:  W Schröder; C A Gutschow; A H Hölscher
Journal:  Langenbecks Arch Surg       Date:  2003-04-01       Impact factor: 3.445

7.  A retrospective study of pattern of recurrence after radical surgery for thoracic esophageal carcinoma with or without postoperative radiotherapy.

Authors:  Yichun Wang; Li Zhang; Dongmei Ye; Wanli Xia; Jun Jiang; Xiumei Wang; Mingxia Zhang; Fan Wang
Journal:  Oncol Lett       Date:  2018-01-16       Impact factor: 2.967

8.  Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients.

Authors:  Shin-ichi Kosugi; Tadashi Nishimaki; Tatsuo Kanda; Satoru Nakagawa; Manabu Ohashi; Katsuyoshi Hatakeyama
Journal:  World J Surg       Date:  2004-06-04       Impact factor: 3.352

9.  Outcomes of patients with stage IVA esophageal cancer (Japanese classification) treated with definitive chemoradiotherapy.

Authors:  Akira Anbai; Makoto Koga; Satoru Motoyama; Mario Jin; Hiroyuki Shibata; Manabu Hashimoto
Journal:  Jpn J Radiol       Date:  2013-02-02       Impact factor: 2.374

10.  Clinical and oncological effects of triplet chemotherapy followed by radical esophagectomy for resectable esophageal cancer associated with unfavorable prognostic factors.

Authors:  Hideaki Shimoji; Tatsuya Kinjo; Hiroyuki Karimata; Masayoshi Nagahama; Tadashi Nishimaki
Journal:  Surg Today       Date:  2013-08-21       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.